Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
PaperCitations, authors & open-access status
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 697 citations, 2020 year and bronze oa status.
697
Citations
2020
Year
bronze
OA Status